• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Nemaura Medical repurposes its CGM to spot coronavirus fevers

April 1, 2020 By Sean Whooley

nemaura-medical-logoNemaura Medical (NSDQ:NMRD) announced today that it is planning to immediately repurpose its SugarBeat continuous glucose monitor (CGM) as a continuous temperature monitor (CTM) to help diagnose fevers in potential cases of COVID-19.

The Loughborough, England-based company said in a news release that its inbuilt temperature sensor is capable of continuously tracking body temperature through the skin, which can potentially help in the battle against coronavirus. Google’s Verily recently announced plans to develop a small body-worn temperature patch that transmits data to a phone application to notify users of fever and support the early diagnosis of viral infections.

Nemaura’s SugarBeat app, launched last month, is designed for glucose monitoring on smart devices and is set to be repurposed for temperature measurement to match with the SugarBeat patch, which is CE-marked in Europe and commercially available.

The company said it is considering its options to expedite the launch of its CTM, including potential partnerships and direct-to-consumer sales. It is also establishing the regulatory process for launching the repurposed platform in a number of areas around the world.

“We see a significant commercial opportunity to utilize our Beat platform technology specifically for CTM purposes with data being automatically sent by low energy Bluetooth to a mobile phone app from which it can then be reviewed by the user and/or sent to a family member or caregiver,” Nemaura CEO Dr. Faz Chowdhury said in the news release. “We believe that there are parallels between family members and caregivers remotely monitoring glucose fluctuations in a person, and monitoring fever caused by viral infections, providing a means of remote tracking and intervention. In the current climate, we see this as an opportunity to contribute to general wellbeing and patient management.”

Nemaura added that it believes there are other uses for its CTM, including tracking ovulation and for predicting and preventing diabetes-related foot complications that can lead to amputation if not detected early enough.

Filed Under: Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: coronavirus, COVID-19, Nemaura Medical

IN CASE YOU MISSED IT

  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor
  • Mosanna launches with $80M to support nasal spray for obstructive sleep apnea

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS